semaglutide and cardiovascular disease Insights into research: Mechanisms, trials, frontiers Real-World Study: Semaglutide Lowers Cardiovascular

How long will I need to keep taking it

Ideal candidates typically have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition such as high blood pressure, pre-diabetes, or sleep apnea

Inflammation can irritate blood vessels and may contribute to plaque buildup, clotting problems, and vascular stress

Gastrointestinal adverse events were the most frequently reported side effects across all retatrutide dose groups , and they occurred primarily during the dose escalation phase of treatment

Reduced Range of Motion and Flexibility Arthritis gradually limits the spine's ability to bend and twist

4 r 4.9% ARR reported at 3 years in prespecified supplementary analysis